Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 16, 2018 - Issue 4
Submit an article Journal homepage
1,839
Views
84
CrossRef citations to date
0
Altmetric
Review

Ceftolozane/tazobactam: place in therapy

Daniele Roberto GiacobbeInfectious Diseases Unit, Ospedale Policlinico San Martino – IRCCS per l’Oncologia and Department of Health Sciences, University of Genoa, Genoa, ItalyCorrespondence[email protected]
View further author information
,
Matteo BassettiInfectious Diseases Clinic, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Integrata Presidio Ospedaliero Universitario Santa Maria della Misericordia, Udine, ItalyView further author information
,
Francesco Giuseppe De RosaDepartment of Medical Sciences, University of Turin, Infectious Diseases, City of Health and Sciences, Turin, ItalyView further author information
,
Valerio Del BonoInfectious Diseases Unit, Ospedale Policlinico San Martino – IRCCS per l’Oncologia and Department of Health Sciences, University of Genoa, Genoa, ItalyView further author information
,
Paolo Antonio GrossiDepartment of Surgical and Morphological Sciences of Clinical Medicine, University of Insubria, Varese, ItalyView further author information
,
Francesco MenichettiInfectious Diseases Clinic, Nuovo Santa Chiara University Hospital, Azienda Ospedaliera Universitaria Pisana, Pisa, ItalyView further author information
,
Federico PeaInstitute of Clinical Pharmacology, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Integrata Presidio Ospedaliero Universitario Santa Maria della Misericordia, Udine, ItalyView further author information
,
Gian Maria RossoliniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy;Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, ItalyView further author information
,
Mario TumbarelloInstitute of Infectious Diseases, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli, Rome, ItalyView further author information
,
Pierluigi VialeDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, ItalyView further author information
,
Claudio ViscoliInfectious Diseases Unit, Ospedale Policlinico San Martino – IRCCS per l’Oncologia and Department of Health Sciences, University of Genoa, Genoa, ItalyView further author information
& on behalf of ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva) show all
Pages 307-320 | Received 18 Dec 2017, Accepted 28 Feb 2018, Published online: 09 Mar 2018

Citations (84)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (12)

Amol S. Nipate, Chetan K. Jadhav, Asha V. Chate, Vidya S. Dofe, Prashant P. Dixit, Prachi Sharma & Charansingh. H. Gill. (2023) Synthesis, Antimicrobial Evaluation, and Docking Studies of Substituted New Chromone Linked 1,2,3-Triazoles. Polycyclic Aromatic Compounds 0:0, pages 1-18.
Read now
Matteo Bassetti, Antonio Vena & Daniele Roberto Giacobbe. (2023) The safety of ceftolozane/tazobactam for the treatment of complicated urinary tract infections. Expert Opinion on Drug Safety 22:7, pages 533-540.
Read now
Yulong Chi, Juan Xu, Nan Bai, Beibei Liang & Yun Cai. (2023) The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies. Expert Review of Anti-infective Therapy 21:2, pages 189-201.
Read now
Rita Murri & Emilio Sacco. (2021) What place does ceftolozane/tazobactam have in the treatment of complicated urinary-tract infections?. Expert Opinion on Pharmacotherapy 22:11, pages 1377-1379.
Read now
Neena Kanwar, Dithi Banerjee, Christopher J. Harrison, Jason G. Newland, Xuan Qin, Danielle M. Zerr, Theoklis Zaoutis & Rangaraj Selvarangan. (2021) Comparative in vitro effectiveness of ceftolozane/tazobactam against pediatric gram-negative drug-resistant isolates. Journal of Chemotherapy 33:5, pages 288-293.
Read now
Paulina Paprocka, Bonita Durnaś, Angelika Mańkowska, Karol Skłodowski, Grzegorz Król, Magdalena Zakrzewska, Michał Czarnowski, Patrycja Kot, Kamila Fortunka, Stanisław Góźdź, Paul B Savage & Robert Bucki. (2021) New β-Lactam Antibiotics and Ceragenins – A Study to Assess Their Potential in Treatment of Infections Caused by Multidrug-Resistant Strains of Pseudomonas aeruginosa. Infection and Drug Resistance 14, pages 5681-5698.
Read now
Ibai Los-Arcos, Joaquin Burgos, Vicenç Falcó & Benito Almirante. (2020) An overview of ceftolozane sulfate + tazobactam for treating hospital acquired pneumonia. Expert Opinion on Pharmacotherapy 21:9, pages 1005-1013.
Read now
Daniele Roberto Giacobbe, Eugenio Ciacco, Corrado Girmenia, Federico Pea, Gian Maria Rossolini, Giovanni Sotgiu, Carlo Tascini, Mario Tumbarello, Pierluigi Viale & Matteo Bassetti. (2020) Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data. Infection and Drug Resistance 13, pages 4697-4711.
Read now
Nicola Petrosillo, Guido Granata, Breida Boyle, Maeve M. Doyle, Biagio Pinchera & Fabrizio Taglietti. (2020) Preventing sepsis development in complicated urinary tract infections. Expert Review of Anti-infective Therapy 18:1, pages 47-61.
Read now
Krisztina M. Papp-Wallace. (2019) The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections. Expert Opinion on Pharmacotherapy 20:17, pages 2169-2184.
Read now
Daniele Roberto Giacobbe, Silvia Corcione, Antonio Salsano, Filippo Del Puente, Simone Mornese Pinna, Francesco Giuseppe De Rosa, Malgorzata Mikulska, Francesco Santini & Claudio Viscoli. (2019) Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery. Expert Opinion on Pharmacotherapy 20:6, pages 751-772.
Read now
Daniele Roberto Giacobbe, Malgorzata Mikulska & Claudio Viscoli. (2018) Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria. Expert Review of Clinical Pharmacology 11:12, pages 1219-1236.
Read now

Articles from other publishers (72)

Satish Bhavsar, Sanjeev Joshi, Vikas Deshmukh, Shivaji Pawar, Bharat Dond, Amit Mishra, Abhijeet K. Kayastha, Ravindra Yeole, Prasad Deshpande, Sachin Bhagwat & Mahesh Patel. (2023) Design and development of an efficient convergent synthetic strategy for novel β-lactam enhancer zidebactam (WCK 5107). Chemical Papers.
Crossref
Asmaul Husna, Md. Masudur Rahman, A. T. M. Badruzzaman, Mahmudul Hasan Sikder, Mohammad Rafiqul Islam, Md. Tanvir Rahman, Jahangir Alam & Hossam M. Ashour. (2023) Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities. Biomedicines 11:11, pages 2937.
Crossref
Mojtaba Shafiekhani, Seyed Amirreza Fatemi, Pouria Hosseini, Fatemeh MarhematiSoniya MohammadiFatemeh SharifiAli Moorkani Kurde Esfahani Pour, Fatemeh Sadeghi Habibabad, Negin Saad AbadiEslam Shorafa & Soha Azadi. (2023) Pharmacokinetic and Pharmacodynamic Considerations of Novel Antibiotic Agents for Pediatric Infections: A Narrative Review. Surgical Infections 24:8, pages 703-715.
Crossref
Ashish Kothari, Radhika Kherdekar, Vishal Mago, Madhur Uniyal, Garima Mamgain, Roop Bhushan Kalia, Sandeep Kumar, Neeraj Jain, Atul Pandey & Balram Ji Omar. (2023) Age of Antibiotic Resistance in MDR/XDR Clinical Pathogen of Pseudomonas aeruginosa. Pharmaceuticals 16:9, pages 1230.
Crossref
Xenia Kostoulias, Christina C. Chang, Jessica Wisniewski, Iain J. Abbott, Helen Zisis, Amanda Dennison, Denis W. Spelman & Anton Y. Peleg. (2023) Antimicrobial susceptibility of ceftolozane-tazobactam against multidrug-resistant Pseudomonas aeruginosa isolates from Melbourne, Australia. Pathology 55:5, pages 663-668.
Crossref
Alberto Corona, Vincenzo De Santis, Andrea Agarossi, Anna Prete, Dario Cattaneo, Giacomina Tomasini, Graziella Bonetti, Andrea Patroni & Nicola Latronico. (2023) Antibiotic Therapy Strategies for Treating Gram-Negative Severe Infections in the Critically Ill: A Narrative Review. Antibiotics 12:8, pages 1262.
Crossref
Francesco Venuti, Lorenza Romani, Maia De Luca, Costanza Tripiciano, Paolo Palma, Maria Chiriaco, Andrea Finocchi & Laura Lancella. (2023) Novel Beta Lactam Antibiotics for the Treatment of Multidrug-Resistant Gram-Negative Infections in Children: A Narrative Review. Microorganisms 11:7, pages 1798.
Crossref
Natalia C Rosas, Jonathan Wilksch, Jake Barber, Jiahui Li, Yanan Wang, Zhewei Sun, Andrea Rocker, Chaille T Webb, Laura Perlaza-Jiménez, Christopher J Stubenrauch, Vijaykrishna Dhanasekaran, Jiangning Song, George Taiaroa, Mark Davies, Richard A Strugnell, Qiyu Bao, Tieli Zhou, Michael J McDonald & Trevor Lithgow. (2023) The evolutionary mechanism of non-carbapenemase carbapenem-resistant phenotypes in Klebsiella spp. eLife 12.
Crossref
Francesco Venuti, Mattia Trunfio, Anne-Grete Martson, Filippo Lipani, Sabrina Audagnotto, Giovanni Di Perri & Andrea Calcagno. (2023) Extended and Continuous Infusion of Novel Protected β-Lactam Antibiotics: A Narrative Review. Drugs 83:11, pages 967-983.
Crossref
Neena Kanwar, Christopher J. Harrison, Morgan A. Pence, Xuan Qin & Rangaraj Selvarangan. (2023) Comparative in vitro antipseudomonal activity of ceftolozane/tazobactam against Pseudomonas aeruginosa isolates from children with cystic fibrosis. Diagnostic Microbiology and Infectious Disease 105:4, pages 115904.
Crossref
I.W. FongI. W. Fong. 2023. New Antimicrobials: For the Present and the Future. New Antimicrobials: For the Present and the Future 39 57 .
Anis Karuniawati, Merry Ambarwulan, Selvi Nafisa Shahab, Yefta Moenadjat, Toar J. M. Lalisang, Neneng Dewi Kurniati, Kuntaman, Vicky Sumarki Budipramana, Tomy Lesmana, Iva Puspitasari, Erik Prabowo, Dwi Putranti Chitra Sasmitasari, Dian Oktavianti Putri & Amrilmaen Badawi. (2022) Ceftolozane/Tazobactam In-Vitro Activity against Clinical Isolates from Complicated Intra-Abdominal Infection Patients in Three Indonesian Referral Hospitals. Antibiotics 12:1, pages 52.
Crossref
Hiba Alaoui Mdarhri, Rachid Benmessaoud, Houda Yacoubi, Lina Seffar, Houda Guennouni Assimi, Mouhsine Hamam, Rihabe Boussettine, Najoie Filali-Ansari, Fatima Azzahra Lahlou, Idrissa Diawara, Moulay Mustapha Ennaji & Mohamed Kettani-Halabi. (2022) Alternatives Therapeutic Approaches to Conventional Antibiotics: Advantages, Limitations and Potential Application in Medicine. Antibiotics 11:12, pages 1826.
Crossref
Bhavna Saroha, Gourav Kumar, Ramesh Kumar, Meena Kumari & Suresh Kumar. (2021) A minireview of 1,2,3‐triazole hybrids with O‐heterocycles as leads in medicinal chemistry. Chemical Biology & Drug Design 100:6, pages 843-869.
Crossref
Shuitao Zhang, Jianxin Li, Tiebo Xiao, Baomin Yang & Yubo Jiang. (2022) Silver-Catalyzed Cascade Cyclization of Amino-NH-1,2,3-Triazoles with 2-Alkynylbenzaldehydes: An Access to Pentacyclic Fused Triazoles. Molecules 27:21, pages 7567.
Crossref
Lauren Hetzler, Marin H. Kollef, Valerie Yuenger, Scott T. Micek & Kevin D. Betthauser. (2022) New antimicrobial treatment options for severe Gram-negative infections. Current Opinion in Critical Care 28:5, pages 522-533.
Crossref
David L Paterson, Matteo Bassetti, Mary Motyl, Matthew G Johnson, Mariana Castanheira, Erin H Jensen, Jennifer A Huntington, Brian Yu, Dominik J Wolf & Christopher J Bruno. (2022) Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial. Journal of Antimicrobial Chemotherapy 77:9, pages 2522-2531.
Crossref
Helen Giamarellou & Ilias Karaiskos. (2022) Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients. Antibiotics 11:8, pages 1009.
Crossref
Mar Ronda, Sandra Pérez‐Recio, Mònica González Laguna, Maria de la Fe Tubau Quintano, Josep Llop Talaveron, Laura Soldevila‐Boixader, Jordi Carratalà, Guillermo Cuervo & Ariadna Padullés. (2022) Ceftolozane/tazobactam for difficult‐to‐treat Gram‐negative infections: A real‐world tertiary hospital experience. Journal of Clinical Pharmacy and Therapeutics 47:7, pages 932-939.
Crossref
Ibrahim Bitar, Tamara Salloum, Georgi Merhi, Jaroslav Hrabak, George F. Araj & Sima Tokajian. (2022) Genomic Characterization of Mutli-Drug Resistant Pseudomonas aeruginosa Clinical Isolates: Evaluation and Determination of Ceftolozane/Tazobactam Activity and Resistance Mechanisms. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Justin F. Hayes. (2022) Fighting Back against Antimicrobial Resistance with Comprehensive Policy and Education: A Narrative Review. Antibiotics 11:5, pages 644.
Crossref
Angela Raffaella Losito, Francesca Raffaelli, Paola Del Giacomo & Mario Tumbarello. (2022) New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review. Antibiotics 11:5, pages 579.
Crossref
Silvana Alfei & Anna Maria Schito. (2022) β-Lactam Antibiotics and β-Lactamase Enzymes Inhibitors, Part 2: Our Limited Resources. Pharmaceuticals 15:4, pages 476.
Crossref
Ravleen Kaur, Pooja Rani, Atanas G. Atanasov, Qushmua Alzahrani, Reena Gupta, Bhupinder Kapoor, Monica Gulati & Pooja Chawla. (2022) Discovery and Development of Antibacterial Agents: Fortuitous and Designed. Mini-Reviews in Medicinal Chemistry 22:7, pages 984-1029.
Crossref
Matteo Bassetti, Alessandra Mularoni, Daniele Roberto Giacobbe, Nadia Castaldo & Antonio Vena. (2022) New Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia. Seminars in Respiratory and Critical Care Medicine 43:02, pages 280-294.
Crossref
Madiha M. Siddiqui, Amol A. Nagargoje, Satish V. Akolkar, Jaiprakash N. Sangshetti, Vijay M. Khedkar, Parshuram M. Pisal & Bapurao B. Shingate. (2022) [HDBU][HSO4]-catalyzed facile synthesis of new 1,2,3-triazole-tethered 2,3-dihydroquinazolin-4[1H]-one derivatives and their DPPH radical scavenging activity. Research on Chemical Intermediates 48:3, pages 1199-1225.
Crossref
Paola Del Giacomo, Francesca Raffaelli, Angela Raffaella Losito, Barbara Fiori & Mario Tumbarello. (2022) XDR-Pseudomonas aeruginosa Outside the ICU: Is There Still Place for Colistin?. Antibiotics 11:2, pages 193.
Crossref
Nabeela Farhat & Asad U. Khan. 2022. Beta-Lactam Resistance in Gram-Negative Bacteria. Beta-Lactam Resistance in Gram-Negative Bacteria 269 286 .
Jan Marco Kern. 2020. DGIM Innere Medizin. DGIM Innere Medizin 1 22 .
Matthaios Papadimitriou-Olivgeris, Damien Jacot & Benoit Guery. 2022. Pseudomonas aeruginosa. Pseudomonas aeruginosa 425 445 .
Paolo Antonio Grossi. 2022. Textbook of Liver Transplantation. Textbook of Liver Transplantation 133 155 .
Matteo Bassetti, Daniele Roberto Giacobbe, Nadia Castaldo, Alessandro Russo & Antonio Vena. (2021) Role of new antibiotics in extended-spectrum β-lactamase-, AmpC- infections. Current Opinion in Infectious Diseases 34:6, pages 748-755.
Crossref
Matteo Bassetti, Chiara Russo, Antonio Vena & Daniele Roberto Giacobbe. (2021) New antibiotics for the treatment of nonfermenting Gram-negative bacteria. Current Opinion in Infectious Diseases 34:6, pages 701-709.
Crossref
Letizia Ottino, Filippo Bartalesi, Beatrice Borchi, Silvia Bresci, Annalisa Cavallo, Ilaria Baccani, Gian Maria Rossolini & Alessandro Bartoloni. (2021) Ceftolozane/tazobactam for Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis adult patients: a case series. European Journal of Clinical Microbiology & Infectious Diseases 40:10, pages 2211-2215.
Crossref
Davide Carcione, Claudia Siracusa, Adela Sulejmani, Valerio Leoni & Jari Intra. (2021) Old and New Beta-Lactamase Inhibitors: Molecular Structure, Mechanism of Action, and Clinical Use. Antibiotics 10:8, pages 995.
Crossref
Bryan D. Lizza, Kevin D. Betthauser, David J. Ritchie, Scott T. Micek & Marin H. Kollef. (2021) New Perspectives on Antimicrobial Agents: Ceftolozane-Tazobactam. Antimicrobial Agents and Chemotherapy 65:7.
Crossref
Silvia Corcione, Tommaso Lupia & Francesco Giuseppe De Rosa. (2021) Novel Cephalosporins in Septic Subjects and Severe Infections: Present Findings and Future Perspective. Frontiers in Medicine 8.
Crossref
Emilio Lence & Concepción González‐Bello. (2021) Bicyclic Boronate β‐Lactamase Inhibitors: The Present Hope against Deadly Bacterial Pathogens. Advanced Therapeutics 4:5.
Crossref
Andrew F. Shorr & Marya D. Zilberberg. (2021) Novelty and nuance in the intensive care unit: new options to combat multidrug resistant pneumonia. Current Opinion in Infectious Diseases 34:2, pages 151-155.
Crossref
Elena Xu, David Pérez-Torres, Paraskevi C. Fragkou, Jean-Ralph Zahar & Despoina Koulenti. (2021) Nosocomial Pneumonia in the Era of Multidrug-Resistance: Updates in Diagnosis and Management. Microorganisms 9:3, pages 534.
Crossref
Ana Motos, Gianluigi Li Bassi, Francesco Pagliara, Laia Fernandez-Barat, Hua Yang, Eli Aguilera Xiol, Tarek Senussi, Francesco A. Idone, Chiara Travierso, Chiara Chiurazzi, Rosanel Amaro, Minlan Yang, Joaquim Bobi, Montserrat Rigol, David P. Nicolau, Gerard Frigola, Roberto Cabrera, Jose Ramirez, Paolo Pelosi, Francesco Blasi, Massimo Antonelli, Antonio Artigas, Jordi Vila, Marin Kollef & Antoni Torres. (2021) Short-Term Effects of Appropriate Empirical Antimicrobial Treatment with Ceftolozane/Tazobactam in a Swine Model of Nosocomial Pneumonia. Antimicrobial Agents and Chemotherapy 65:2.
Crossref
Matteo Bassetti, Antonio Vena, Denise Battaglini, Paolo Pelosi & Daniele Roberto Giacobbe. (2020) The role of new antimicrobials for Gram-negative infections in daily clinical practice. Current Opinion in Infectious Diseases 33:6, pages 495-500.
Crossref
Matteo Bassetti, Daniele R. Giacobbe, Chiara Robba, Paolo Pelosi & Antonio Vena. (2020) Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?. Current Opinion in Infectious Diseases 33:6, pages 474-481.
Crossref
Krisztina M. Papp-Wallace, Andrew R. Mack, Magdalena A. Taracila & Robert A. Bonomo. (2020) Resistance to Novel β-Lactam–β-Lactamase Inhibitor Combinations. Infectious Disease Clinics of North America 34:4, pages 773-819.
Crossref
Matteo Bassetti, Antonio Vena, Chiara Sepulcri, Daniele Roberto Giacobbe & Maddalena Peghin. (2020) Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance. Antibiotics 9:9, pages 632.
Crossref
Shivakumar S. Jalde & Hyun Kyung Choi. (2020) Recent advances in the development of β-lactamase inhibitors. Journal of Microbiology 58:8, pages 633-647.
Crossref
András Fodor, Birhan Addisie Abate, Péter Deák, László Fodor, Ervin Gyenge, Michael G. Klein, Zsuzsanna Koncz, Josephat Muvevi, László Ötvös, Gyöngyi Székely, Dávid Vozik & László Makrai. (2020) Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides—A Review. Pathogens 9:7, pages 522.
Crossref
Adela Alvarez-Buylla, Mike Allen, Dan Betts, Sean Bennett, Irene Monahan, Tim Planche, Cressida Auckland, Karen Bowker, Helen Chesterfield, Martino Dall’antonia, Mathew Diggle, Noha El Sakka, Wael Elamin, Abid Hussain, Jon Lambourne, John Perry, Timothy Planche, Michael Pryzbylo, Peter Wilson & Mandy Wootton. (2020) Multicentre study of the in vitro activity of ceftolozane/tazobactam and other commonly used antibiotics against Pseudomonas aeruginosa isolates from patients in the UK . JAC-Antimicrobial Resistance 2:2.
Crossref
Silvia Garazzino, Elena Altieri, Erika Silvestro, Giulia Pruccoli, Carlo Scolfaro & Elisabetta Bignamini. (2020) Ceftolozane/Tazobactam for Treating Children With Exacerbations of Cystic Fibrosis Due to Pseudomonas aeruginosa: A Review of Available Data. Frontiers in Pediatrics 8.
Crossref
Matteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe, Marco Falcone, Giusy Tiseo, Maddalena Giannella, Renato Pascale, Marianna Meschiari, Margherita Digaetano, Alessandra Oliva, Cristina Rovelli, Novella Carannante, Angela Raffaella Losito, Sergio Carbonara, Michele Fabiano Mariani, Antonio Mastroianni, Gioacchino Angarano, Mario Tumbarello, Carlo Tascini, Paolo Grossi, Claudio Maria Mastroianni, Cristina Mussini, Pierluigi Viale, Francesco Menichetti, Claudio Viscoli, Alessandro Russo, Matteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe, Claudio Viscoli, Alessandro Russo, Marco Falcone, Giusy Tiseo, Francesco Menichetti, Stefano Verdenelli, Silvia Fabiani, Nadia Castaldo, Davide Pecori, Alessia Carnellutti, Filippo Givone, Elena Graziano, Maria Merelli, Barbara Cadeo, Maddalena Peghin, Maddalena Giannella, Renato Pascale, Pierlugi Viale, Annamaria Cattelan, Ludovica Cipriani, Davide Coletto, Cristina Mussini, Margherita Digaetano, Carlo Tascini, Novella Carannante, Claudio Maria Mastroianni, Russo Gianluca, Alessandra Oliva, Maria Rosa Ciardi, Camilla Ajassa, Tiziana Tieghi, Mario Tumbarello, Angela Raffaella Losito, Francesca Raffaelli, Paolo Grossi, Cristina Rovelli, Stefania Artioli, Giorgia Caruana, Roberto Luzzati, Giulia Bontempo, Nicola Petrosillo, Alessandro Capone, Giuliano Rizzardini, Massimo Coen, Matteo Passerini, Antonio Mastroianni, Giuliana Guadagnino, Filippo Urso, Guglielmo Borgia, Ivan Gentile, Alberto Enrico Maraolo, Massimo Crapis, Sergio Venturini, Giustino Parruti, Francesca Trave, Gioacchino Angarano, Sergio Carbonara, Michele Fabiano Mariani, Massimo Girardis, Antonio Cascio, Claudia Gioe, Marco Anselmo & Emanuele Malfatto. (2020) Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study). Open Forum Infectious Diseases 7:5.
Crossref
Helio S. Sader, Cecilia G. Carvalhaes, Leonard R. Duncan & Dee Shortridge. (2020) Antimicrobial Activity of Ceftolozane-Tazobactam and Comparators against Clinical Isolates of Haemophilus influenzae from the United States and Europe. Antimicrobial Agents and Chemotherapy 64:5.
Crossref
Daniele Roberto Giacobbe, Carolina Saffioti, Angela Raffaella Losito, Matteo Rinaldi, Caterina Aurilio, Cesare Bolla, Silvia Boni, Guglielmo Borgia, Novella Carannante, Giovanni Cassola, Giancarlo Ceccarelli, Silvia Corcione, Daniela Dalla Gasperina, Francesco Giuseppe De Rosa, Chiara Dentone, Stefano Di Bella, Nicoletta Di Lauria, Marcello Feasi, Marco Fiore, Sara Fossati, Erica Franceschini, Andrea Gori, Guido Granata, Sara Grignolo, Paolo Antonio Grossi, Giuliana Guadagnino, Filippo Lagi, Alberto Enrico Maraolo, Valeria Marinò, Maria Mazzitelli, Alessandra Mularoni, Alessandra Oliva, Maria Caterina Pace, Andrea Parisini, Francesca Patti, Nicola Petrosillo, Vincenzo Pota, Francesca Raffaelli, Marianna Rossi, Antonella Santoro, Carlo Tascini, Carlo Torti, Enrico Maria Trecarichi, Mario Venditti, Pierluigi Viale, Alessio Signori, Matteo Bassetti, Valerio Del Bono, Maddalena Giannella, Malgorzata Mikulska, Mario Tumbarello & Claudio Viscoli. (2020) Use of colistin in adult patients: A cross-sectional study. Journal of Global Antimicrobial Resistance 20, pages 43-49.
Crossref
David Aguilera-Alonso, Luis Escosa-García, Jesús Saavedra-Lozano, Emilia Cercenado & Fernando Baquero-Artigao. (2020) Carbapenem-Resistant Gram-Negative Bacterial Infections in Children. Antimicrobial Agents and Chemotherapy 64:3.
Crossref
Ilias Karaiskos & Helen Giamarellou. (2020) Carbapenem-Sparing Strategies for ESBL Producers: When and How. Antibiotics 9:2, pages 61.
Crossref
Marianna Criscuolo & Enrico Maria Trecarichi. (2020) Ceftazidime/Avibactam and Ceftolozane/Tazobactam for Multidrug-Resistant Gram Negatives in Patients with Hematological Malignancies: Current Experiences. Antibiotics 9:2, pages 58.
Crossref
Matteo Bassetti, Christian Eckmann, Daniele Roberto Giacobbe, Massimo Sartelli & Philippe Montravers. (2019) Post-operative abdominal infections: epidemiology, operational definitions, and outcomes. Intensive Care Medicine 46:2, pages 163-172.
Crossref
Daniele Roberto Giacobbe, Sara Mora, Mauro Giacomini & Matteo Bassetti. (2020) Machine Learning and Multidrug-Resistant Gram-Negative Bacteria: An Interesting Combination for Current and Future Research. Antibiotics 9:2, pages 54.
Crossref
Matteo Bassetti, Elena Graziano, Marco Berruti & Daniele Roberto Giacobbe. (2019) The role of fosfomycin for multidrug-resistant gram-negative infections. Current Opinion in Infectious Diseases 32:6, pages 617-625.
Crossref
Fekade B. Sime, Melissa Lassig-Smith, Therese Starr, Janine Stuart, Saurabh Pandey, Suzanne L. Parker, Steven C. Wallis, Jeffrey Lipman & Jason A. Roberts. (2019) Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction. Antimicrobial Agents and Chemotherapy 63:10.
Crossref
José-Manuel Ortiz de la Rosa, Patrice Nordmann & Laurent Poirel. (2019) ESBLs and resistance to ceftazidime/avibactam and ceftolozane/tazobactam combinations in Escherichia coli and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 74:7, pages 1934-1939.
Crossref
Ilias Karaiskos, Styliani Lagou, Konstantinos Pontikis, Vasiliki Rapti & Garyphallia Poulakou. (2019) The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How. Frontiers in Public Health 7.
Crossref
Mario Pezzi, Anna Maria Scozzafava, Anna Maria Giglio, Renata Vozzo, Patrizia Dina Casella, Simona Paola Tiburzi, Lucio Cosco & Mario Verre. (2019) Use of Ceftolozane/Tazobactam in a Case of Septic Shock by Puerperal Sepsis. Case Reports in Obstetrics and Gynecology 2019, pages 1-6.
Crossref
Cecilia G. Carvalhaes, Mariana Castanheira, Helio S. Sader, Robert K. Flamm & Dee Shortridge. (2019) Antimicrobial activity of ceftolozane–tazobactam tested against gram-negative contemporary (2015–2017) isolates from hospitalized patients with pneumonia in US medical centers. Diagnostic Microbiology and Infectious Disease 94:1, pages 93-102.
Crossref
Matteo Bassetti, Maddalena Peghin, Antonio Vena & Daniele Roberto Giacobbe. (2019) Treatment of Infections Due to MDR Gram-Negative Bacteria. Frontiers in Medicine 6.
Crossref
Paola Del Giacomo, Angela Raffaella Losito & Mario Tumbarello. (2019) The role of carbapenem-resistant pathogens in cSSTI and how to manage them. Current Opinion in Infectious Diseases 32:2, pages 113-122.
Crossref
Matteo Bassetti, Nadia Castaldo, Annamaria Cattelan, Cristina Mussini, Elda Righi, Carlo Tascini, Francesco Menichetti, Claudio Maria Mastroianni, Mario Tumbarello, Paolo Grossi, Stefania Artioli, Novella Carannante, Ludovica Cipriani, Davide Coletto, Alessandro Russo, Margherita Digaetano, Angela Raffaella Losito, Maddalena Peghin, Alessandro Capone, Stefano Nicolè, Antonio Vena, Matteo Bassetti, Antonio Vena, Nadia Castaldo, Davide Pecori, Elda Righi, Alessia Carnellutti, Filippo Givone, Elena Graziano, Maria Merelli, Barbara Cadeo, Maddalena Peghin, Annamaria Cattelan, Ludovica Cipriani, Davide Coletto, Cristina Mussini, Margherita Digaetano, Carlo Tascini, Novella Carannante, Francesco Menichetti, Stefano Verdenelli, Silvia Fabiani, Claudio Maria Mastroianni, Russo Gianluca, Alessandra Oliva, Maria Rosa Ciardi, Camilla Ajassa, Tiziana Tieghi, Mario Tumbarello, Angela Raffaella Losito, Francesca Raffaelli, Paolo Grossi, Cristina Rovelli, Stefania Artioli, Giorgia Caruana, Roberto Luzzati, Giulia Bontempo, Nicola Petrosillo, Alessandro Capone, Giuliano Rizzardini, Massimo Coen, Matteo Passerini, Antonio Mastroianni, Filippo Urso, Maria Francesca Bianco, Guglielmo Borgia, Ivan Gentile, Alberto Enrico Maraolo, Massimo Crapis, Sergio Venturini, Giustino Parruti, Francesca Trave, Gioacchino Angarano, Sergio Carbonara, Michele Fabiano Mariani, Massimo Girardis, Antonio Cascio, Claudia Gioé, Marco Anselmo & Emanuele Malfatto. (2019) Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience. International Journal of Antimicrobial Agents 53:4, pages 408-415.
Crossref
Laurent Poirel, José-Manuel Ortiz De La Rosa, Nicolas Kieffer, Véronique Dubois, Aurélie Jayol & Patrice Nordmann. (2019) Acquisition of Extended-Spectrum β-Lactamase GES-6 Leading to Resistance to Ceftolozane-Tazobactam Combination in Pseudomonas aeruginosa . Antimicrobial Agents and Chemotherapy 63:1.
Crossref
Matteo Bassetti, Antonio Vena, Alessandro Russo, Antony Croxatto, Thierry Calandra & Benoit Guery. (2018) Rational approach in the management of Pseudomonas aeruginosa infections. Current Opinion in Infectious Diseases 31:6, pages 578-586.
Crossref
O. C. Smibert, M. A. Paraskeva, G. Westall & Greg Snell. (2018) An Update in Antimicrobial Therapies and Infection Prevention in Pediatric Lung Transplant Recipients. Pediatric Drugs 20:6, pages 539-553.
Crossref
Matteo Bassetti, Elda Righi, Antonio Vena, Elena Graziano, Alessandro Russo & Maddalena Peghin. (2018) Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria. Current Opinion in Critical Care 24:5, pages 385-393.
Crossref
Paolo Antonio Grossi. (2018) Donor-derived infections, lessons learnt from the past, and what is the future going to bring us. Current Opinion in Organ Transplantation 23:4, pages 417-422.
Crossref
Kamaleddin H. M. E. Tehrani & Nathaniel I. Martin. (2018) β-lactam/β-lactamase inhibitor combinations: an update. MedChemComm 9:9, pages 1439-1456.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.